Anti-tumor product from clostridium perfringens

Details Anti-tumor product from clostridium perfringens Anti-tumor product from clostridium perfringens

C - Chemistry, Metallurgy

12

P

195/33

C12P 19/00 (2006.01)

Patent

CA 1063048

Abstract of the Disclosure Wild strain Lechien of the organism Clostridium perfringens is attenuated with nitrosoguanidine. To produce an anti-tumor preparation, the attenuated organism is grown first on a growth medium then on a sporulation medium and the resulting growth recovered as a bacillary suspension, a spore suspension, or culture filtrates. The preparation in any of these forms has the property of inhibiting the growth of Ehrlich's solid tumor, of reducing the tumor size, and lengthening the survival time of the host. - 1 -

212447

Affiliated with

Also associated with

Rating

Anti-tumor product from clostridium perfringens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-tumor product from clostridium perfringens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor product from clostridium perfringens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-188513